"Lungemiltbrand (profylakse efter udsættelse for smitte og kurativ behandling)" for perorale og intravenøse farmaceutiske formuleringer.
The proposed wording of the therapeutic indications was as follows: “ Inhalation anthrax (post exposure prophylaxis and curative treatment )” for oral and IV pharmaceutical presentations.